Christopher J. Hoffmann

Author

Also Known As

C HOFFMANN, C Hoffmann, C J Hoffmann, C. Hoffmann, C. J. Hoffmann, CJ Hoffmann, Carly Hoffmann, Chris Hoffmann, Chris J Hoffmann, Chris J. Hoffmann

227

Publications

5.3K

Citations

H-Index

115

Concepts

All Affiliations

Johns Hopkins University Johns Hopkins Medicine Aurum Institute University of the Witwatersrand London School of Hygiene & Tropical Medicine

About

Christopher J. Hoffmann is an author at Johns Hopkins University specializing in medicine, public health, and hiv.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	18	639
2	Public Health	14	16	507
3	Nursing	4	4	85
4	Arts	1	1	80
5	Education	1	1	19

Christopher J. Hoffmann

Publications

4.2K

Citations

H-Index

Page 1

	Year	Citations
Life Expectancies of South African Adults Starting Antiretroviral Treatment: Collaborative Analysis of Cohort Studies Leigh F. Johnson, Joël Mossong, Rob Dorrington, PLoS Medicine	2013	443
Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study John Gregson, Michele W. Tang, Nicaise Ndembi, The Lancet Infectious Diseases	2016	274
Gender Differences in Survival among Adult Patients Starting Antiretroviral Therapy in South Africa: A Multicentre Cohort Study Morna Cornell, Michael Schomaker, Daniela Garone, PLoS Medicine	2012	250
Hepatotoxicity in an African antiretroviral therapy cohort: the effect of tuberculosis and hepatitis B Christopher J. Hoffmann, Salome Charalambous, Chloe L. Thio, AIDS	2007	171
Chromosome Structure and Human Immunodeficiency Virus Type 1 cDNA Integration: Centromeric Alphoid Repeats Are a Disfavored Target Sandrine Carteau, Christopher J. Hoffmann, Frederic D. Bushman Journal of Virology	1998	150
Hepatitis B Virus Infection and Response to Antiretroviral Therapy (ART) in a South African ART Program Christopher J. Hoffmann, Salome Charalambous, Desmond J. Martin, Clinical Infectious Diseases	2008	138
Hepatitis B and long-term HIV outcomes in coinfected HAART recipients Christopher J. Hoffmann, Eric C. Seaberg, Stephen Young, AIDS	2009	125
Monitoring and switching of first-line antiretroviral therapy in adult treatment cohorts in sub-Saharan Africa: collaborative analysis Andreas D. Haas, Olivia Keiser, Éric Balestre, The Lancet HIV Preventive MedicineHealth PolicyTreatment And PreventionGlobal HealthFirst-line Antiretroviral Therapy	2015	121
Viremia, Resuppression, and Time to Resistance in Human Immunodeficiency Virus (HIV) Subtype C during First‐Line Antiretroviral Therapy in South Africa Christopher J. Hoffmann, Salome Charalambous, John Sim, Clinical Infectious Diseases	2009	115
Clonally expanded HIV-1 proviruses with 5′-leader defects can give rise to nonsuppressible residual viremia Jennifer A. White, Fengting Wu, Saif Yasin, Journal of Clinical Investigation	2023	84

Page 1